Search Results - therapeutics+%3e+women%27s+health

5 Results

Sort By:

Combination of Insulin-like Growth Factor-1 Receptor (IGF1R) or Insulin Receptor Inhibitors with Immune Checkpoint Inhibitors in Management of Triple-Negative Breast Cancer (UCLA Case No. 2020-872)

UCLA researchers in the Department Joe C. Wen School of Nursing have developed a novel targeted therapy for triple-negative breast cancer with a potential synergy with immunotherapy. BACKGROUND: Triple-negative breast cancer (TNBC) accounts for about 10-15% of women with breast cancer (BC), but its mortality rate is disproportionally high, causing...

Published: 3/2/2026 | Inventor(s): Nalo Hamilton

Keywords(s):

Category(s): Therapeutics > Oncology, Therapeutics > Oncology > Oncology Immunotherapy, Therapeutics > Metabolism And Endocrinology, Diagnostic Markers > Cancer, Therapeutics > Women's Health

Wearable Sweat Sensor for Ovulatory Hormone Monitoring (UCLA Case No. 2024-127)

UCLA researchers in the Department of Psychiatry and the Department of Behavioral Sciences have developed a skin patch that tracks estradiol, progesterone, and luteinizing hormone for the accurate prediction of fertility windows. BACKGROUND: Female reproductive hormones monitoring is required to accurately predict daily fertility for decision-making,...

Published: 3/2/2026 | Inventor(s): Anne Andrews

Keywords(s):

Category(s): Medical Devices > Monitoring And Recording Systems, Medical Devices > FemTech, Diagnostic Markers, Therapeutics > Women's Health

Generating Ovarian Follicle Cells From Human Induced Pluripotent Stem Cells (UCLA Case No. 2021-066)

UCLA researchers in the Department of Molecular Cell Developmental Biology have developed a human induced pluripotent stem cell-derived model of ovarian follicle cells that can be used to study women’s reproductive health. BACKGROUND: Ovarian follicles are essential components of the female reproductive system. They nurture and support the development...

Published: 3/2/2026 | Inventor(s): Amander Clark

Keywords(s):

Category(s): Life Science Research Tools > Cell Lines, Therapeutics > Women's Health

A novel ER beta ligand prodrug to treat neurodegenerative conditions (UCLA Case No. 2017-168)

Researchers from the Department of Neurology and the Department of Chemistry and Biochemistry at UCLA have developed a novel ERβ ligand prodrug that is structurally designed to confer neuroprotection in neurodegenerative conditions (multiple sclerosis, Alzheimer’s disease, and cognitive deficits of menopause in otherwise healthy women). BACKGROUND: Multiple...

Published: 3/2/2026 | Inventor(s): Rhonda Voskuhl, Michael Jung

Keywords(s): Autoimmune, Cns, Therapeutics & Vaccines

Category(s): Therapeutics > CNS and Neurology, Therapeutics > Autoimmune, Therapeutics, Therapeutics > Women's Health

Novel Vaginal Drug Delivery Device (UCLA Case No. 2020-444)

Summary: UCLA researchers in the Departments of Biomedical Engineering and Medicine have developed vaginal drug delivery devices for the administration of contraceptives and antibiotics. Background: Globally, 1.9 billion women of reproductive age (15-49 years) use contraceptives. An additional 190 million women would use phrophylactics/contraceptives...

Published: 3/2/2026 | Inventor(s): Leena Nathan, Song Li, Tamara Grisales, Mohammad Mahdi Hasani Sadrabadi

Keywords(s):

Category(s): Platforms > Drug Delivery, Platforms > Drug Delivery > Antibody Delivery Platforms, Platforms > Drug Delivery > Other Polymers, Therapeutics > Women's Health